GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Qomel Co (SAU:9600) » Definitions » YoY EBITDA Growth

Qomel Co (SAU:9600) YoY EBITDA Growth : 11.51% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Qomel Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Qomel Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 11.51%.

Qomel Co's EBITDA per Share for the six months ended in Dec. 2024 was ﷼2.16.

Qomel Co YoY EBITDA Growth Historical Data

The historical data trend for Qomel Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qomel Co YoY EBITDA Growth Chart

Qomel Co Annual Data
Trend Dec23 Dec24
YoY EBITDA Growth
- 37.88

Qomel Co Semi-Annual Data
Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth - - 77.26 11.51

Qomel Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Qomel Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(4.102-2.975)/ | 2.975 |
=37.88 %

Qomel Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(2.16-1.937)/ | 1.937 |
=11.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qomel Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Qomel Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Qomel Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Qomel Co (SAU:9600) » Definitions » YoY EBITDA Growth
Comparable Companies
SAU:9592 SAU:9572 HKSE:06618 HKSE:00241 WBA TSE:3088 BSP:RADL3 JSE:CLS TSE:3349 SHSE:603939 SAU:4164 TSE:3391 TSE:9989 TSE:7649 TSE:3141 MEX:FRAGUAB TSE:3549 SHSE:603883 SAU:4163 JSE:DCP
Traded in Other Exchanges
N/A
Address
3221 Prince Mamdouh bin Abdul Aziz Street, Sulaymaniyah District, Riyadh, SAU
Website
https://www.qomel.com
Qomel Co is a Saudi Arabian-based healthcare company that provides high-quality medicines and innovative medical services whose core business focuses on institutional and government supply through a professional field force and an in-depth knowledge of the local business environment They offer services such as pharmaceutical and medical supplies.

Qomel Co Headlines

No Headlines